Evotec SE (ETR:EVT)
3.490
-0.014 (-0.40%)
Jul 29, 2026, 2:20 PM CET
Evotec SE Employees
Evotec SE had 4,526 employees as of March 31, 2026. The number of employees decreased by 240 or -5.04% compared to the same quarter last year.
Employees
4,526
Change
-240
Growth
-5.04%
Revenue / Employee
€164,613
Profits / Employee
€42,836
Market Cap
622.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 4,526 | -240 | -5.04% |
| Dec 31, 2025 | 4,467 | -273 | -5.76% |
| Sep 30, 2025 | 4,788 | -219 | -4.37% |
| Jun 30, 2025 | 4,759 | -263 | -5.24% |
| Mar 31, 2025 | 4,766 | -289 | -5.72% |
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Sep 30, 2024 | 5,007 | -79 | -1.55% |
| Jun 30, 2024 | 5,022 | -45 | -0.89% |
| Mar 31, 2024 | 5,055 | 103 | 2.08% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Sep 30, 2023 | 5,086 | 371 | 7.87% |
| Jun 30, 2023 | 5,067 | 546 | 12.08% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Sep 30, 2022 | 4,715 | 634 | 15.54% |
| Jun 30, 2022 | 4,521 | 607 | 15.51% |
| Mar 31, 2022 | 4,354 | 619 | 16.57% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,783 |
| Bayer Aktiengesellschaft | 87,757 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| RHÖN-KLINIKUM Aktiengesellschaft | 19,184 |
| Gerresheimer AG | 13,528 |
| Redcare Pharmacy NV | 2,163 |
| Eckert & Ziegler SE | 1,100 |
Evotec SE News
- 6 days ago - Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management - Business Wire
- 12 days ago - Evotec price target lowered to EUR 3.50 from EUR 4.50 at Deutsche Bank - TheFly
- 13 days ago - Evotec downgraded to Hold from Buy at Berenberg - TheFly
- 13 days ago - Evotec price target lowered to $2.40 from $3 at BofA - TheFly
- 14 days ago - EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 14 days ago - Evotec price target lowered to $4 from $7 at H.C. Wainwright - TheFly
- 14 days ago - Evotec downgraded to Hold from Buy at TD Cowen - TheFly
- 14 days ago - Evotec Q2 Earnings Call Highlights - MarketBeat